AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Infinity Bio Appoints Brian McKelligon as Chief Executive Officer
PRIVATEMar 18, 2026•6 months ago
Position
Chief Executive Officer
Company
Infinity Bio
Brian McKelligon
BaltimoreBiotechnology
Description
Infinity Bio has appointed Brian McKelligon as Chief Executive Officer, who will guide the company's growth and expansion. With extensive experience in life sciences, he will focus on accelerating the commercial potential of the proprietary MIPSA technology.
Company Information
Company
Infinity Bio
Location
6200 SEAFORTH ST.
Baltimore, Maryland, United States
About
Infinity Bio is a technology company that provides detailed insights into the immune system using its proprietary antibody profiling platform. The company’s core technology comprehensively measures the antibody reactome, revealing the targets of individual immune responses against all known human viruses, human proteins (autoimmunity), and allergen proteins. Infinity's assay, MIPSA, was developed at Johns Hopkins University in Ben Larman's Lab of Precision Immunology. It builds off decades of work in the fields of genomics, proteomics, immunology, and bioinformatics. Our assay was engineered to enable best-in-class turnaround times and cost. With a team of experienced professionals and a state-of-the-art facility, we are poised to make a significant impact to research and for our customers.
Fundz sees it the moment Infinity Bio changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BaltimoreBiotechnology